ROC earnings analysis
What we found in ROC's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q excerpt does not include the current-period income statement, balance sheet, cash-flow statement, segment results or MD&A, so operating trends and valuation metrics cannot be assessed from the available text. The principal updates are the pending ZTC acquisition, which carries closing, dilution and future expense risks, and litigation with approximately $179.1 million of claimed damages. Management reported effective disclosure controls as of June 30, 2026, but provided no quantitative guidance.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Controls assessed as effective
- Management concluded that disclosure controls and procedures were effective as of June 30, 2026. The company also reported no changes during the three months ended June 30, 2026 that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
- ZTC acquisition initiated
- ROC entered into a Purchase Agreement to acquire ZTC on June 23, 2026. The proposed consideration includes $500,000 in cash, $2,500,000 in restricted common-stock shares and up to $7,000,000 in revenue-share payments over seven years.
- No unregistered sales or repurchases
- The filing states that no unregistered securities were sold during the quarter and that the company performed no stock repurchases in any month of the quarter.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- ZTC closing and cost risk
- The ZTC transaction remains subject to regulatory approvals, third-party consents, key-personnel employment agreements and completion of audits of ZTC's 2024 and 2025 financial statements. ROC expects significant legal, accounting and advisory costs whether or not the transaction closes.
- Dilution and acquisition expense
- The ZTC acquisition could dilute existing shareholders through $2,500,000 of restricted shares and $500,000 of restricted stock units. ROC expects forfeitable equity and revenue-share amounts to be recognized as compensation expense after closing, potentially reducing reported operating results materially.
- $179.1 million litigation claim
- ROC is defending litigation filed in March 2026 in the High Court of England and Wales in which the plaintiff seeks approximately $179.1 million. The company has recorded no loss accrual because the matter is at an early stage and cannot currently be estimated; insurance may not cover the full cost.
What they said about what is next.
No quantitative revenue or EPS guidance was provided in the supplied 10-Q excerpt.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 14, 2026
- ROC experienced a significant decline in revenue of 20% year-over-year to $2.55 million in Q1 2026, alongside a negative EPS of -$0.18. Despite lower revenues in key segments like ROC SDK and ROC Enroll, products like…
- 10-K · March 31, 2026
- ROC positions itself as a U.S.-native leader in Vision AI and multimodal biometrics, emphasizing NIST-ranked accuracy and extreme algorithmic efficiency (e.g., a latent fingerprint algorithm that is described as capable…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing ROC makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever